학술논문
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 4 January 2023, 41(1):109-118)
Subject
Language
English
ISSN
18732518
0264410X
0264410X